Johnson & Johnson (JNJ) at Wells Fargo Conference Notes
JNJ grows its pharma business in the US through market share gains and penetration by way of clinical evidence, as opposed to pricing “Overall, for Johnson & Johnson, in total, price is a very small component of growth, in sort … Continued